Nutritional supplements for age-related macular degeneration

Current Opinion in Ophthalmology

Volumn 21, Issue 3, 2010, Pages 184-189

  Krishnadev, Nupura ^a   Meleth, Annal D ^a   Chew, Emily Y ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Age related macular degeneration; Antioxidant vitamins; Lutein; V 3 fatty acids; Zeaxanthin

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; COPPER; CUPRIC OXIDE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; XANTHOPHYLL; ZEAXANTHIN; ZINC; ZINC OXIDE;

AMINO ACID METABOLISM; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DIET; DIET SUPPLEMENTATION; DISEASE COURSE; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; LOW DRUG DOSE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; VISUAL IMPAIRMENT;

ANTIOXIDANTS; FATTY ACIDS, OMEGA-3; HUMANS; LUTEIN; MACULAR DEGENERATION; NUTRITIONAL SUPPORT; VITAMINS; XANTHOPHYLLS;

EID: 77951298125     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32833866ee     Document Type: Review

References (34)

1. Congdon N, O'Colmain B, Klaver CC, et al., for the Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122:477-485. (Pubitemid 38456282)
2. Rosenfeld PJ, Brown DM, Heier JS, et al., for the MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. NEJM 2006; 355:1419-1431.
3. Brown DM, Kaiser PK, Michels M, et al., for the ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. NEJM 2006; 355:1432-1444.
4. Coleman H, Chew E. Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 2007; 18:220-223.
5. The Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001; 119:1417-1436.
6. Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age related macular degeneration. Cochrane Database Syst Rev 2006:CD000254.
7. Tan JSL, Wang JJ, Flood V, et al. Dietary antioxidants and the long term incidence of age-related macular degeneration: the Blue Mountain Eye study. Ophthalmology 2008; 115:334-341.
8. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005; 294:3101-3107.
9. Christen WG, Glynn RJ, Chew EY, et al. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology 2009; 116:2386-2392.
10. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II: a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000; 10:124-134.
11. Evans JR, Henshaw KS. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev 2008:CD000253.
12. Bazan NG. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989; 312:95-112.
13. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005; 24:87-138.
14. Tan JSL, Wang JJ, Flood V, Mitchel Pl. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountain Eye study. Arch Ophthalmol 2009; 127:656-665.
15. Chong EWT, Robman LD, Simpson JA, et al. Fat consumption and its association with age-related macular degeneration. ArchOphthalmol 2009; 127:674-680.
16. Chiu CJ, Klein R, Milton RC, et al. Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease study supplements? Br J Ophthalmol 2009; 93:1241-1246.
17. SanGiovanni JP, Chew EY, Clemons TE, et al., Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS report No. 20. Arch Ophthalmol 2007; 125:671-679.
18. SanGiovanni JP, Chew EY, Agrón E, et al., Age-Related Eye Disease Study Research Group. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report No. 23. Arch Ophthalmol 2008; 126:1274-1279.
19. SanGiovanni JP, Agró n E, Meleth AD, et al. {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease study. Am J Clin Nutr 2009; 90:1601-1607.
20. Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 2008; 126:826-833.
21. LaRowe TL, Mares JA, Snodderly M, et al., CAREDS Macular Pigment Study Group. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease study: an ancillary study of the Women's Health Initiative. Ophthalmology 2008; 115:876-883.
22. Parisi V, Tedeschi M, Gallinaro G, et al. Carotenoids and antioxidants in the age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 2008; 115:324-333.
23. Seddom JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272:1413-1420.
24. Moeller SM, Parekh N, Tinker L, et al. CAREDS Research Study Group. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol 2006; 124:1151-1162.
25. Age-Related Eye Disease Study Research Group. The relationship of dietary carotenoids and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 22. Arch Ophthalmol 2007; 125:1225-1232.
26. Mares JA, LaRowe TL, Snodderly DM, et al., CAREDSMacular Pigment Study Group and Investigators. Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-related Eye Disease study (CAREDS): ancillary study of the Women's Health Initiative. Am J Clin Nutr 2006; 84:1107-1122.
27. Axer-Siegel R, Bourla D, Ehrlich R, et al. Association of neovascular agerelated macular degeneration and hyperhomocysteinemia. Am J Ophthalmol 2004; 137:84-89.
28. Rochtchina E, Wang JJ, Flood VM, Mitchell P. Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye study. Am J Ophthalmol 2007; 143:344-346.
29. Kamburoglu G, Gumus K, Kadayifcilar S, Eldem B. Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2006; 244:565-569.
30. Seddon JM, Gensler G, Klein ML, Milton RC. Evaluation of plasma homocysteine and risk of age-related macular degeneration. Am J Ophthalmol 2006; 141:201-203.
31. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005; 82:806-812.
32. Christen WG, Glynn R, Chew EY, et al. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women. The Women's Antioxidant and Folic Acid Cardiovascular study. Arch Intern Med 2009; 169:335-341.
33. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006; 124:1754-1760.
34. Rein DB, Wittenborn JS, Zhang X, et al., for the Vision Health Cost-Effectiveness Study Group. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol 2009; 127:533-540.